Canadian Psychiatric Association
 

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)


Editorial
Challenges at the Pharmaceutical–Physician Boundary
Quentin Rae-Grant
(PDF)

Guest Editorial
Suicide: The Persisting Challenge
Isaac Sakinofsky
(PDF)


In Review
The Neurobiology of Suicide and Suicidality

Kees van Heeringen

(PDF)

Assessing Suicidal Youth With Antisocial, Borderline, or Narcissistic Personality Disorder
Paul S Links, Brent Gould, Ruwan Ratnayake

(PDF)


Original Research
Sexsomnia — A New Parasomnia?

Colin M Shapiro, Nikola N Trajanovic, J Paul Fedoroff

(PDF)

A Case–Control Study on Psychological Symptoms in Sleep Apnea-Hypopnea Syndrome
Weihua Yue, Wei Hao, Pozi Liu, Tieqiao Liu, Ming Ni, Qi Guo

(PDF)

Suicide Attempts in Turkey: Results of the WHO–EURO Multicentre Study on Suicidal Behaviour
Halise Devrimci-Ozguven, Is1k Say1l

(PDF)


Review Paper
Adverse Effects Associated With Physical Restraint

Wanda K Mohr, Theodore A Petti, Brian D Mohr

(PDF)


Brief Communication
Insight and Neuropsychological Function in Patients With Schizophrenia and Bipolar Disorder With Psychotic Features

Luca Arduini, Artemis Kalyvoka, Paolo Stratta, Osvaldo Rinaldi, Enrico Daneluzzo, Alessandro Rossi

(PDF)

Time of Day Influences Nonattendance at Urgent Short-Term Mental Health Unit in Victoria, British Columbia
Rivian Weinerman, Vi Glossop, Randy Wong, Lara Robinson, Karen White, Rif Kamil

(PDF)

Diabetes Mellitus and Impaired Glucose Tolerance in Patients With Schizophrenia
Mythily Subramaniam, Siow-Ann Chong, Elaine Pek

(PDF)


Book Reviews
(PDF)

Language Impairment and Psychopathology in Infants, Children and Adolescents.
Reviewed by
JH Beitchman, MD

Women’s Mental Health: A Comprehensive Textbook.
Reviewed by
Gail Erlick Robinson, MD, DPsych, FRCPC

Psychiatric and Cognitive Disorders in Parkinson’s Disease.
Reviewed by
Erwin K Koranyi, MD

Un jour la santé.
Reviewed by
Paul Beaudry, MD, FRCP

Seeking Safety: A Treatment Manual for Posttraumatic Stress Disorder and Substance Abuse.
Reviewed by
George A Fraser, MD

Treatment-Resistant Mood Disorders.
Reviewed by
Sagar V Parikh, MD, FRCPC


Letters to the Editor
(PDF)

QTc Prolongation: Chlorpromazine and High-Dosage Olanzapine

Should Lipids be Monitored During the First Year of Treatment with an Atypical Antipsychotic?

Quetiapine May Induce Mania: A Case Report

Insight, Knowledge, and Beliefs About Illness in First-Episode Psychosis

The Symptoms of Atypical Depression

Potential Risk of Diabetes Mellitus With the Use of Atypical Antipsychotic Medication

Clozapine-Induced Aplastic Anemia in a Patient With Parkinson’s Disease

Early-Onset Obsessive–Compulsive Disorder

Treatment Noncompliance With Orally Disintegrating Olanzapine Tablets

Letters to the Editor

The Symptoms of Atypical Depression

Dear Editor:

Studies of the diagnostic criteria of atypical depression have recently increased. In one such study, Parker and others sampled individuals with major depressive disorder (MDD) (1) and, after finding weak correlations and associations among only some atypical symptoms, reported weak support for DSM-IV-TR atypical features criteria (2). (According to these criteria, an individual must present a bipolar or MDD major depressive episode or dysthymic disorder, always including mood reactivity plus at least 2 of the following: increased weight or appetite, hypersomnia, significant energy loss, and long-standing sensitivity to interpersonal rejection, but no melancholic or catatonic features.) In another study, Posternak and Zimmerman found no correlations among atypical symptoms in subjects who mainly suffered from MDD (3). An important limitation of these studies is that conclusions are based only on subjects with MDD, while in the DSM-IV-TR, atypical features can occur in individuals with either depressive or bipolar disorders (BDs). Atypical depression may be different in BD, compared with MDD. Studies by Benazzi (4) and Angst and others (5) found atypical features to be much more common in BD II than in MDD, which accords with the official DSM-IV-TR statement (p 421). In the Benazzi study of consecutively presenting outpatients, atypical features were present in 53.5% of subjects with BD II (n = 241) and in 23.7% of subjects with MDD (n = 164) (z = 5.9, P = 0.0000) (4). These 2 studies have an important difference from the Parker and others (1) and Posternak and Zimmerman (3) studies: they include mixed samples (that is, BD II plus MDD). Benazzi found significant associations among atypical symptoms (4). However, while most atypical symptoms were significantly associated in Benazzi’s BD II sample, only a few were significantly associated in his MDD sample. This suggests that atypical depression may differ in depressive and bipolar disorders (6). Angst and others also found significant associations among atypical symptoms (5), but in the Angst and others study, atypical depression was not studied separately in the BD II and MDD sample (which were combined in the analyses). Parker and others (1), Posternak and Zimmerman (3), and Angst and others (5) concluded that mood reactivity should not have the priority it has in DSM-IV-TR (according to which it must always be present). Benazzi (4) came to the same conclusion, but only for the MDD sample. In the BD II sample, mood reactivity was significantly associated with atypical symptoms, and depression patients with mood reactivity had significantly more atypical symptoms than did depression patients without mood reactivity. These findings support the inclusion of mood reactivity among the atypical features in BD II but not in MDD. Consequently, atypical depression should probably be studied independently in MDD and in BDs. Parker and others stated that hypothesizing a different response to antidepressants to support the diagnostic validity of atypical features (currently its main validator) is an unusual approach (1). Family history is a more important diagnostic validator (6,7). It has been shown that atypical features are strongly associated with a positive family history of BD (8)—a finding further supporting the distinction between atypical depression in MDD and in BD. Further studies are required to find a new definition of atypical depression, beyond that offered in the DSM-IV-TR.

References

1. Parker G, Roy K, Mitchell P, Wilhelm K, Malhi G, Hadzi-Pavlovic D. Atypical depression: a reappraisal. Am J Psychiatry 2002;159:1470–9.

2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington (DC): American Psychiatric Association; 2000.

3. Posternak MA, Zimmerman M. Partial validation of the atypical features subtype of major depressive disorder. Arch Gen Psychiatry 2002;59:70–6.

4. Benazzi F. Should mood reactivity be included in the DSM-IV atypical features specifier? Eur Arch Psychiatry Clin Neurosci 2002;252:135–40.

5. Angst J, Gamma A, Sellaro R, Zhang H, Merikangas K. Towards validation of atypical depression in the community: results of the Zurich cohort study. J Affect Disord 2002;72:125–38.

6. Akiskal HS. Classification, diagnosis and boundaries of bipolar disorders: a review. In: Maj M, Akiskal HS, Lopez-Ibor JJ, Sartorius N, editors. Bipolar disorder. Chichester (UK): John Wiley and Sons; 2002. p 1–52.

7. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry 1970;126: 983–7.

8. Benazzi F. Atypical depression and its relation to bipolar spectrum. In: Marneros A, Goodwin FK, editors. Mixed states. Cambridge (UK): Cambridge University Press. Forthcoming.

Franco Benazzi, MD
Forli, Italy




CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2002 | Index RCP des auteurs 2002
Subject Index to 2002 | Index RCP des sujets 2002
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil